dfree810,,2019-05-22 14:31:00,22.14,MRNA TWST Do you foresee in this year a mini frenzy of MA around the gene therapy or even the cell therapy companiesMr Singh I dont I still have a lot of friends in the BD business development space The RNA space is probably more amenable ALNY has actually had a couple of projects outlicensed and MRNA which I am covering has had earlystage products outlicensed to MRK and to AZN To me thats always a good signWhat I hear about gene therapy just from industry folks in the business development space is that the manufacturing problems there are so huge and so much money has to be put in there and those manufacturing issues might not be able to be solvedtwstcominterviewthefirs
mouchodinero,True,2019-05-22 13:06:00,22,MRNA this company needs some good PR and exposure No volume because few people know about it
Niko8675309,False,2019-05-22 10:39:00,22.29,MRNA wall street does not like bio this is going back to the teens nothing but pain
Niko8675309,True,2019-05-22 09:40:00,22.675,MRNA We need volume cmon lets see green today
Niko8675309,,2019-05-22 09:38:00,22.647,MRNA no volume again will go down for more pain today
